Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Geneyx Analysis offers an all-encompassing solution for managing next-generation sequencing (NGS) data, efficiently transforming FASTQ files into clinical reports tailored for both hospital and commercial laboratories. This cutting-edge platform incorporates machine learning and artificial intelligence capabilities to uncover new biomedical insights, enhancing diagnostic efficiency and reducing turnaround times. By delivering a fully transparent and user-friendly interface, Geneyx Analysis empowers clinicians and researchers with complete control over data interpretation and simplifies the challenges associated with managing in-house bioinformatics workflows. Users can customize protocols to suit various gene panels, exomes, and genomes, while our extensive annotation engine facilitates the analysis of all genetic variants, including structural and copy number variations, as well as regulatory elements. In combination, Geneyx Analysis streamlines the diagnostic journey from sequencer output to finalized report, while also serving as a valuable resource for the discovery of novel variants. This platform not only enhances clinical capabilities but also paves the way for groundbreaking research in genomics.
Description
Pharmaceutical companies require extensive genomic data to effectively implement precision medicine initiatives; however, they frequently rely on merely 10% of the available information for their decisions. Genomenon provides access to the complete dataset. Their Prodigy™ Patient Landscapes offer a streamlined and economical solution for natural history research, aiding the creation of therapies for rare diseases by deepening understanding of both retrospective and prospective health data. Utilizing an advanced AI-driven methodology, Genomenon conducts a thorough evaluation of each patient documented in the medical literature in a significantly reduced timeframe. Ensure you capture all relevant insights by exploring every genomic biomarker featured in published studies. Each scientific claim is substantiated by concrete evidence drawn from the medical literature, allowing researchers to uncover all genetic drivers and identify variants recognized as pathogenic in accordance with ACMG clinical standards, thereby enhancing the development process of targeted therapies. By leveraging this comprehensive approach, pharma companies can enhance their research effectiveness and ultimately improve patient outcomes.
API Access
Has API
No
API Access
Has API
Yes
Integrations
Google Cloud Platform
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
Geneyx
Founded
2018
Country
Netherlands
Website
geneyx.com/geneyxanalysis/
Vendor Details
Company Name
Genomenon
Country
United States
Website
www.genomenon.com/pharma/